Management of Urethral Bleeding in Patients with Recent Carotid Endarterectomy

Antiplatelet Management After Carotid Endarterectomy

The American College of Chest Physicians guidelines recommend single antiplatelet therapy with either clopidogrel or aspirin for patients following carotid endarterectomy to reduce the risk of stroke and other cardiovascular events 3, 4
For patients with symptomatic carotid stenosis, including recent carotid endarterectomy, clopidogrel or aspirin-extended-release dipyridamole is preferred over aspirin alone 4
Single antiplatelet therapy is generally recommended over dual antiplatelet therapy following carotid endarterectomy due to bleeding risk considerations 1, 3
Following carotid endarterectomy, long-term antiplatelet therapy is strongly recommended to reduce the risk of stroke and other cardiovascular events 2, 3

For patients with urethral bleeding on dual antiplatelet therapy, the primary approach should be to identify and treat the underlying cause of the bleeding rather than discontinuing antiplatelet therapy 5
If the bleeding is minor and self-limiting, continue antiplatelet therapy to prevent thrombotic complications following carotid endarterectomy 1, 2
If the bleeding is severe or persistent, consider temporarily interrupting one antiplatelet agent while maintaining aspirin therapy if possible, and resume full antiplatelet therapy as soon as hemostasis is achieved 5
The severity of bleeding should be assessed through clinical parameters such as hemoglobin levels, vital signs, and presence of active bleeding 5

Platelet function testing may be considered to guide antiplatelet management in patients with bleeding complications, though evidence for clinical benefit is limited 6
Proton pump inhibitors should be considered for gastrointestinal protection in patients on dual antiplatelet therapy 6, 5
The decision to modify antiplatelet therapy must carefully balance the risk of thrombotic complications against the risk of continued bleeding 5